Profit Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Hold |
329,822
| – | – | 1.4% | 29 |
|
|
2025
Q1 | $1.51M | Hold |
329,822
| – | – | 1.41% | 31 |
|
|
2024
Q4 | $1.58M | Hold |
329,822
| – | – | 1.27% | 36 |
|
|
2024
Q3 | $1.55M | Sell |
329,822
-241,502
| -42% | -$1.13M | 1.22% | 38 |
|
|
2024
Q2 | $3.23M | Buy |
571,324
+351,000
| +159% | +$1.98M | 2.02% | 22 |
|
|
2024
Q1 | $906K | Sell |
220,324
-168,950
| -43% | -$694K | 0.51% | 55 |
|
|
2023
Q4 | $1.64M | Buy |
389,274
+62,277
| +19% | +$263K | 0.94% | 38 |
|
|
2023
Q3 | $1.41M | Sell |
326,997
-1,671
| -0.5% | -$7.22K | 1% | 37 |
|
|
2023
Q2 | $2.17M | Sell |
328,668
-4,195
| -1% | -$27.6K | 1.41% | 27 |
|
|
2023
Q1 | $2.26M | Sell |
332,863
-2,091
| -0.6% | -$14.2K | 1.49% | 25 |
|
|
2022
Q4 | $2.48M | Hold |
334,954
| – | – | 1.74% | 24 |
|
|
2022
Q3 | $3.31M | Buy |
334,954
+53,064
| +19% | +$524K | 2.53% | 15 |
|
|
2022
Q2 | $3.07M | Hold |
281,890
| – | – | 2.26% | 20 |
|
|
2022
Q1 | $3.19M | Buy |
281,890
+43,830
| +18% | +$496K | 1.97% | 24 |
|
|
2021
Q4 | $3.74M | Buy |
238,060
+159,906
| +205% | +$2.51M | 2.35% | 17 |
|
|
2021
Q3 | $1.34M | Sell |
78,154
-178,392
| -70% | -$3.06M | 0.93% | 31 |
|
|
2021
Q2 | $5.52M | Hold |
256,546
| – | – | 2.92% | 9 |
|
|
2021
Q1 | $3.85M | Sell |
256,546
-5,345
| -2% | -$80.3K | 2.19% | 17 |
|
|
2020
Q4 | $3.44M | Hold |
261,891
| – | – | 2.21% | 18 |
|
|
2020
Q3 | $2.53M | Buy |
261,891
+70,901
| +37% | +$685K | 1.56% | 24 |
|
|
2020
Q2 | $2.19M | Buy |
190,990
+85,756
| +81% | +$981K | 1.53% | 26 |
|
|
2020
Q1 | $1.09M | Buy |
+105,234
| New | +$1.09M | 1.02% | 46 |
|